Device and method for controlled delivery of active substance into the skin

• US 7,979,117 B2
• Filed: 10/23/2002
• Issued: 07/12/2011
• Est. Priority Date: 10/24/2001
• Status: Expired due to Fees

• Current Assignee: Power Flex Ltd.
• Original Assignee: Power Paper Ltd. (Products To Go, Inc.)
• Inventors: Arbel, Giora, Gross, Yossi, Nitzan, Zvi, Tamarkin, Dov, Mavor, Daniela, Harel, Nurit
• Primary Examiner(s): Stigell; Theodore J
• Assistant Examiner(s): Schmidt; Emily
• Application Number:
  US10/493,386
• Publication Number:
  US 20040267189A1
• Time in Patent Office: 3,184 Days
• Field of Search: 604 20- 22, 604/501, 6048901-8921, 601/17
• US Class Current: 604/20
• CPC Class Codes: A61N 1/044 Shape of the electrode
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428

Abstract

An apparatus for dermal treatment of an active substance having certain physical properties having a flexible, wearable patch conformable to the contour of a skin surface and having: a first electrode adapted to communicate the active substance into the skin by application of an electrical current on the skin surface, a second electrode capable of closing an electrical circuit with the skin surface, a power source for providing a current and voltage connected through a conductive media to the first and second electrode, and an apparatus for substantially controlling penetration depth of the active substance by selecting at least one variable from a plurality of variables.

Claims

1. A flexible dermal patch having a top surface and a skin contacting bottom surface, the patch comprising:

at least one negative electrode and at least one positive electrode for electrical coupling to the skin portion and/or skin appendage of a subject, wherein the at least one negative electrode and the at least one positive electrode are disposed substantially coplanar on the skin contacting bottom surface and a first electrode of the at least one negative electrode and the at least one positive electrode is disposed on a skin contacting side of the skin contacting bottom surface;

an internal flexible power source electrically coupled to the at least one negative electrode and the at least one positive electrode, wherein the flexible power source powers the patch and is disposed in or on the patch; and

at least one separator comprising a porous non-conductive material retaining a conductive fluid/composition therein, said at least one separator disposed on a second electrode of the at least one negative electrode and the at least one positive electrode, the at least one separator being for preventing contact between at least one of the at least one negative electrode and the at least one positive electrode and the skin portion, wherein the first electrode does not include a separator comprising a porous non-conductive material disposed thereon.

2. The flexible dermal patch of claim 1, wherein the at least one negative electrode, the at least one positive electrode and the flexible power source are disposed on a patch body in spaced relation to each other to avoid contact between each of the electrodes.

3. The flexible dermal patch of claim 1, wherein the patch is for treatment of a disorder selected from the group consisting of wrinkles, acne, aging skin, dry skin, pigmentation disorders, age spots, rosacea, puffy eyes, cellulite, warts and psoriasis.

4. The flexible dermal patch of claim 1, wherein the conductive fluid/composition comprises a hydrogel.

6. The flexible dermal patch of claim 1, wherein the patch is for treating a fungal infection of a nail of a subject, and wherein the conductive fluid/composition comprises an antifungal agent.

7. The flexible dermal patch of claim 6, wherein when the flexible dermal patch is placed on the skin and/or nail of the subject, the at least two electrodes are disposed in spaced relation to each other and are electrically coupled to the skin and/or nail with the conductive composition acting as an interface between at least one of the at least one negative electrode and the at least one positive electrode and the skin and/or nail, and the flexible power source can provide electricity for delivering the antifungal agent to the skin and/or nail for treating the fungal infection.

8. The flexible dermal patch of claim 6, wherein the at least one negative electrode and the at least one positive electrode and the flexible power source are disposed in spaced relation to each other on a patch body.

9. The flexible dermal patch of claim 6, wherein the conductive fluid/composition further comprises a gelling agent with minimal competing ions.

10. The flexible dermal patch of claim 6, wherein the conductive fluid/composition further comprises a stratum corneum hydrating agent.

11. The flexible dermal patch of claim 1, wherein the patch is for treating a fungal infection, and wherein treatment comprises delivery of a substance to a subject, and the fungal infection is an infection of the subject selected from the group consisting of a dermatophyte skin infection, dermatophyte infection of a skin appendage, a dermatophyte infection of a dead tissue of the skin, a dermatophyte infection of the stratum corneum of the skin, dermatophyte infection of a nail, dermatophyte infection of hair, Candida skin infection, Candida infection of a skin appendage, Candida infection of the skin in an occluded area and/or intertriginous area and Candida infection of the skin in a moist area.

12. The flexible dermal patch of claim 6, wherein the fungal infection is a dermatophyte infection of a nail.

13. The flexible dermal patch of claim 6, further comprising electrical circuitry coupled to the dermal patch for controlling the level or duration of an electric current supplied by the flexible power source.

14. The flexible dermal patch of claim 13, wherein the electrical circuitry comprises an integrated circuit configured to control the delivered dosage of the antifungal agent.

15. The flexible dermal patch of claim 6, wherein the dermal patch is wearable.

16. The flexible dermal patch of claim 6, further comprising an attachment mechanism for attaching the dermal patch to the skin.

17. The flexible dermal patch of claim 1, wherein the flexible power source comprises a flexible electrochemical cell.

18. The flexible dermal patch of claim 6, further comprising a removable cover encapsulating the at least one negative electrode, the at least one positive electrode, and the flexible power source.

19. The flexible dermal patch of claim 6, wherein the antifungal agent is delivered by a mechanism selected from the group consisting of iontophoresis, electrophoresis, electroporation, electroosmosis and a combination thereof.

20. The flexible dermal patch of claim 6, wherein the flexible power source is configured for supplying a predetermined constant level of electric current.

21. The flexible dermal patch of claim 17, wherein the flexible electrochemical cell comprises:

a flexible layer open liquid state electrochemical cell which comprises a first layer of insoluble negative pole, a second layer of insoluble positive pole and a third layer of aqueous electrolyte, the third layer being disposed between the first and second layers and including;

(a) a deliquescent material for keeping the open cell wet at all times;

(b) an electroactive soluble material for obtaining required ionic conductivity; and

(c) a water-soluble polymer for obtaining a required viscosity for adhering the first and the second layers to the third layer.

22. The flexible dermal patch of claim 6, wherein the conductive fluid/composition comprises a hydrogel.

23. A kit for treating a fungal infection of the skin and/or skin appendage of a subject, comprising the flexible dermal patch of claim 6, wherein the separator is configured to be attached to the patch before use.

24. The flexible dermal patch of claim 1, further comprising a removable cover encapsulating the at least one negative electrode, the at least one positive electrode, and the flexible power source.

26. The flexible dermal patch of claim 1, wherein the separator is attachable.

27. A method of treating puffy eyes in a subject suffering therefrom comprising:

applying the patch of claim 1 to the eye area of the subject;

introducing current; and

iontophoretically delivering an active substance to the subject to treat the puffy eyes.

28. A method of treating puffy eyes in a subject suffering therefrom comprising:

applying the patch of claim 1 to the eye area of the subject;

iontophoretically delivering the conductive fluid/composition to the subject to treat the puffy eyes.

29. The flexible dermal patch of claim 1, wherein the first electrode comprises a conductive adhesive hydrogel disposed on the skin contacting side thereof.

30. The flexible dermal patch of claim 29, wherein the patch is adapted for contact with the skin by the adhesive hydrogel on first electrode and by the separator on the second electrode.

31. The flexible dermal patch of claim 1, wherein the flexible patch is for treatment of a disorder selected from the group consisting of aging skin, dry skin, sun damaged skin, wrinkles, age spots, various hyperpigmented spots, melasma, puffy eyes, acne, redness of the skin, telangiectasia, cellulite, obesity, dermatitis, contact dermatitis, atopic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of the hands and feet, generalized exfoliative dermatitis, stasis dermatitis, bacterial infections of the skin, cellulitis, acute lymphangitis, lymphadenitis, erysipelas, cutaneous abscesses, necrotizing subcutaneous infections, Staphylococcal scalded skin syndrome, folliculitis, furuncles, hidradenitis suppurativa, carbuncles, paronychial infections, erythrasma, viral skin infection, herpes, disorders of the hair follicles and sebaceous glands, rosacea, perioral dermatitis, hypertrichosis, alopecia, pseudofolliculitis barbae, keratinous cyst, scaling popular diseases, psoriasis, pityriasis rosea, lichen planus, pityriasis, rubra pilaris, pigmentation disorders, hypopigmentation, hyperpigmentation, warts, scars, benign tumours, moles, dysplastic nevi, skin tags, lipomas, angiomas, pyogenic granuloma, seborrheic keratoses, dermatofibroma, keratoacanthoma, keloid, malignant tumors, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, malignant melanoma, Paget'"'"'s disease of the nipples, Kaposi'"'"'s sarcoma, a fungal infection, pain, inflammation, and a combination thereof.

5. A kit comprising:

(a) a flexible dermal patch having a top surface and a skin contacting bottom surface, the patch comprising a power source and at least two substantially coplanar electrodes in electrical connection with the power source, the electrodes for electrical coupling with a skin portion and/or skin appendage of a subject, wherein the at least two electrodes are disposed on the skin contacting bottom surface and a first electrode of the at least two electrodes is disposed on a skin contacting side of the skin contacting bottom surface; and

(b) at least one retainer comprising at least one separator comprising a porous non-conductive material for retaining a conductive fluid, the conductive fluid being for deposition on a second electrode of the at least two electrodes and/or topical application onto the skin portion and/or skin appendage of the subject, wherein the retainer is for disposing on the second electrode and for preventing contact between the second electrode and the skin portion, wherein the first electrode does not include a separator comprising a porous non-conductive material disposed thereon;

the patch being designed and configured for delivering an electric current through the skin and the conductive fluid, for introduction of current and/or voltage to the skin portion and/or skin appendage, and/or transdermal or intradermal delivery of at least one substance.

25. The kit of claim 5 for treatment of a fungal infection of the skin and/or skin appendage of a subject wherein the conductive fluid comprises an antifungal agent.

32. The kit of claim 5, wherein the kit is for treatment of a disorder selected from the group consisting of aging skin, dry skin, sun damaged skin, wrinkles, age spots, various hyperpigmented spots, melasma, puffy eyes, acne, redness of the skin, telangiectasia, cellulite, obesity, dermatitis, contact dermatitis, atopic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of the hands and feet, generalized exfoliative dermatitis, stasis dermatitis, bacterial infections of the skin, cellulitis, acute lymphangitis, lymphadenitis, erysipelas, cutaneous abscesses, necrotizing subcutaneous infections, Staphylococcal scalded skin syndrome, folliculitis, furuncles, hidradenitis suppurativa, carbuncles, paronychial infections, erythrasma, viral skin infection, herpes, disorders of the hair follicles and sebaceous glands, rosacea, perioral dermatitis, hypertrichosis, alopecia, pseudofolliculitis barbae, keratinous cyst, scaling popular diseases, psoriasis, pityriasis rosea, lichen planus, pityriasis, rubra pilaris, pigmentation disorders, hypopigmentation, hyperpigmentation, warts, scars, benign tumours, moles, dysplastic nevi, skin tags, lipomas, angiomas, pyogenic granuloma, seborrheic keratoses, dermatofibroma, keratoacanthoma, keloid, malignant tumors, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, malignant melanoma, Paget'"'"'s disease of the nipples, Kaposi'"'"'s sarcoma, a fungal infection, pain, and inflammation.